(BCI) abrdn Bloomberg All - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US0032611040

BCI: ETF, Futures, Index

The abrdn Bloomberg All Commodity Strategy K-1 Free ETF (BCI) is designed to track the performance of the Bloomberg Commodity IndexSM (BCOM), a benchmark that represents a fully collateralized investment in a diversified basket of physical commodity futures contracts. The index is structured to provide exposure to a broad range of commodities, including energy, agriculture, metals, and livestock, with weights determined by liquidity and production levels. The fund achieves its investment objective by holding exchange-traded commodity futures contracts through a wholly-owned subsidiary domiciled in the Cayman Islands, allowing it to efficiently access global commodity markets. As a non-diversified fund, it may concentrate its investments in a limited number of commodities or sectors, which can lead to higher volatility compared to diversified portfolios.

The ETF provides investors with a liquid and transparent way to gain exposure to the commodities market without directly holding physical assets or individual futures contracts. By utilizing a Cayman Islands subsidiary, the fund aims to optimize its tax efficiency and operational structure, particularly for U.S. investors. The funds holdings are periodically rolled to maintain exposure to the underlying commodities, and it is designed to minimize contango effects that can impact futures-based investments. The BCOM index is widely regarded as a leading benchmark for commodity futures investments, with a focus on liquidity, diversification, and representation of global commodity markets.

Ticker Symbol: BCI Exchange: NYSE ARCA Type: ETF Country Origin: USA ETF Category: Commodities Broad Basket Average Volume 20d: 711,100 Last Price: 20.39 SMA 20: 20.47 SMA 50: 20.87 SMA 200: 19.91 ATR: 0.29 AUM: 1,442.12M USD 3-Month Forecast Based on the provided and , the following insights can be derived: - Technical Outlook: - The ETF is currently trading slightly below its 20-day and 50-day moving averages (20.47 and 20.87, respectively), indicating near-term weakness. - However, it remains above its 200-day moving average (19.91), suggesting longer-term strength and potential support at current levels. - The Average True Range (ATR) of 0.29 indicates low volatility, with expected price fluctuations likely to remain within a narrow range in the near term. - Fundamental Outlook: - With assets under management (AUM) of $1.442 billion, the ETF maintains sufficient liquidity to execute its investment strategy without significant market impact. - Commodity markets are expected to remain influenced by macroeconomic factors, including inflation trends, supply chain dynamics, and geopolitical developments. - Energy and agricultural commodities may experience heightened volatility due to supply-demand imbalances, while industrial metals could see support from infrastructure spending and renewable energy initiatives. - Key Levels to Monitor: - Support: $20.00 (historical support level and psychological benchmark). - Resistance: $21.00 (recent resistance level and upper end of the current trading range).

Additional Sources for BCI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BCI ETF Overview

Market Cap in USD 1,443m
Category Commodities Broad Basket
TER 0.26%
IPO / Inception 2017-03-30

BCI ETF Ratings

Growth Rating 56.0
Fundamental -
Dividend Rating 47.6
Rel. Strength 9.59
Analysts -
Fair Price Momentum 20.16 USD
Fair Price DCF -

BCI Dividends

Dividend Yield 12m 3.22%
Yield on Cost 5y 5.74%
Annual Growth 5y 34.12%
Payout Consistency 61.4%
Payout Ratio %

BCI Growth Ratios

Growth Correlation 3m -55.7%
Growth Correlation 12m 63.1%
Growth Correlation 5y 60.3%
CAGR 5y 12.69%
CAGR/Max DD 5y 0.48
Sharpe Ratio 12m 0.14
Alpha -6.52
Beta 0.385
Volatility 14.92%
Current Volume 251.8k
Average Volume 20d 389.3k
What is the price of BCI shares?
As of May 23, 2025, the stock is trading at USD 20.64 with a total of 251,808 shares traded.
Over the past week, the price has changed by +0.24%, over one month by -0.24%, over three months by -2.87% and over the past year by +0.47%.
Is abrdn Bloomberg All a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, abrdn Bloomberg All (NYSE ARCA:BCI) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.99 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BCI is around 20.16 USD . This means that BCI is currently overvalued and has a potential downside of -2.33%.
Is BCI a buy, sell or hold?
abrdn Bloomberg All has no consensus analysts rating.
What are the forecasts for BCI share price target?
According to our own proprietary Forecast Model, BCI abrdn Bloomberg All will be worth about 22.2 in May 2026. The stock is currently trading at 20.64. This means that the stock has a potential upside of +7.36%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 22.2 7.4%